Disease Markers

Disease Markers / 2019 / Article

Comment on “Pretreatment Hepatitis C Virus NS5A/NS5B Resistance-Associated Substitutions in Genotype 1 Uruguayan Infected Patients”

  • Sana Eybpoosh | Mona Kiminezhad Malaie |
  •  Article ID 8698263 |
  •  Published 05 Nov 2018
  • | View Article

Response to: Comment on “Pretreatment Hepatitis C Virus NS5A/NS5B Resistance-Associated Substitutions in Genotype 1 Uruguayan Infected Patients”

  • Fabián Aldunate | Natalia Echeverría | ... | Pilar Moreno |
  •  Article ID 2520302 |
  •  Published 05 Feb 2019

Letter to the Editor | Open Access

Volume 2019 |Article ID 2520302 | 4 pages | https://doi.org/10.1155/2019/2520302

Response to: Comment on “Pretreatment Hepatitis C Virus NS5A/NS5B Resistance-Associated Substitutions in Genotype 1 Uruguayan Infected Patients”

Academic Editor: Emilia Hadziyannis
Received05 Nov 2018
Accepted08 Nov 2018
Published05 Feb 2019

We are very grateful to Dr. Sana Eybpoosh and Dr. Mona Kiminezhad for their valuable comments and suggestions [1] on our recent article entitled “Pretreatment Hepatitis C Virus NS5A/NS5B Resistance-Associated Substitutions in Genotype 1 Uruguayan Infected Patients” [2].

We have carefully reviewed all the comments [1] and hope that the provided responses will address the concerns on validity and generalizability of our results.

The first concern raised by Eybpoosh and Kiminezhad refers to the possibility that our samples may have reached partial or full “substitution saturation” given the fact that they were collected from chronic hepatitis C virus (HCV) cases. As stated, this phenomenon of saturation occurs more rapidly in fast evolving pathogens [3] and it is well established that HCV exhibits a fast evolutionary rate ranging from 10−3 to 10−4 substitutions/site/year [46]. As substitution saturation could decrease the phylogenetic signal in the sequence alignment, the authors suggest that it could affect the quality and accuracy of our phylogenetic inferences. However, likelihood mapping studies had previously been performed on all of our datasets in order to determine the phylogenetic signal of our aligned sequences [7]. Unfortunately, we did not include these results in our publication. In all cases, the likelihood mapping results confirmed that over 91% of the trees rendered fully resolved topologies (Figure 1). Our NS5A and NS5B datasets for genotyping purposes (Figure 1 in [2]) included 31 Uruguayan strains and 58 or 59 strains, respectively, corresponding to different HCV subtypes and genotypes isolated elsewhere. In particular, as shown in Figure 1(a), our NS5A dataset (953 nucleotide long) showed that 93.8% of trees are fully resolved, whereas for our NS5B dataset (361 nucleotide long) this percentage was slightly lower (91.9%, Figure 1(b)), but in both cases, these results suggested sufficient phylogenetic signal for our subsequent analyses. The NS5A genotype 1a dataset, used to analyse evolutionary relationships (Figure 2 in [2]), included 20 Uruguayan HCV subtype 1a strains and 237 HCV subtype 1a strains isolated elsewhere (1119 nucleotide long). This dataset showed the highest percentage of fully resolved trees (95.5%, Figure 1(c)).

Despite the abovementioned results, we agree with the comment of the authors that we could have assessed the substitution saturation of our data. Therefore, we have addressed this issue using DAMBE [8], as suggested by them. Figure 2 shows the results obtained for the Uruguayan strains when plotting the observed transitions and transversions of all codon positions against a GTR-corrected genetic distance (NS5A, Figure 2(a) and NS5B, Figure 2(b)). These results indicate that our sequences, derived from chronically infected patients, have not yet reached substitution saturation which is evidenced by a higher rate of transitions than transversions, both increasing with the genetic distance.

In addition to analysing Uruguayan strains, we have tested the substitution saturation in all of our datasets using Xia’s method [9, 10]. This test provides an index of substitution saturation (Iss) and compares it with a critical Iss (Iss.c) which corresponds to a value at which the sequences will begin to fail to recover the true tree. In addition, it is performed assuming two extreme tree topologies (symmetrical vs. asymmetrical). Since the computer simulation is limited to sequences and our datasets exceed this number, DAMBE randomly samples subsets of 4, 8, 16, and 32 sequences multiple times and performs the test for each subset. When considering NS5A genotype 1a dataset for evolutionary relationships (257 sequences), no saturation was found (Table 1). This is evidenced by Iss values significantly smaller than Iss.c for both tree topologies which argues for a dataset with little substitution saturation [10]. This, in turn, supports the evolutionary relationships inferred in Figure 2 in [2]. When performing Xia’s method on NS5A and NS5B datasets for genotyping purposes (89 and 90 sequences, respectively, corresponding to all known HCV genotypes and several subtypes), the results are slightly different. As shown in Table 2, only when sample subsets of 32 sequences are considered and under an extremely asymmetric tree topology assumption, the results suggest that our datasets would be poor for phylogenetic studies (Iss > Iss.c, ). Nevertheless, it is worth noting that our likelihood mapping results (Figure 1) are indicative of good phylogenetic signal for both datasets. In addition, the topologies of the reconstructed phylogenetic trees (Figure 1 in [2]) seem to be more symmetric-like, and under the symmetric tree topology assumption, all Iss values are significantly smaller than Iss.c, regardless of the number of sequences sampled. In conclusion, considering the tree topology as well as the likelihood mapping studies, the genotype assignment is presumably correct.


sequencesIssSymmetrical topologyAsymmetrical topology
Iss.cSymIss.cAsym

40.1240.8250.00000.7930.0000
80.1290.7950.00000.6910.0000
160.1370.7780.00000.5850.0000
320.1440.7570.00000.4580.0000

Iss: index of substitution saturation; Iss.c: critical index of substitution saturation; : value for two-tailed tests.

sequencesIssSymmetrical topologyAsymmetrical topology
Iss.cSymIss.cAsym

NS5A40.4340.8190.00000.7870.0000
80.4270.7870.00000.6810.0000
160.4330.770.00000.5710.0000
320.4480.7460.00000.4390.7354

NS5B40.3540.7850.00000.7560.0000
80.3610.7390.00000.6280.0000
160.3590.6940.00000.4850.0000
320.3650.6870.00000.3580.8151

Iss: index of substitution saturation; Iss.c: critical index of substitution saturation; : value for two-tailed tests.

Eybpoosh and Kiminezhad also drew attention to the small number, apparently not randomly sampled, of HCV patients enrolled in our study. To better comprehend our sampling diversity, we must introduce some demographical data about our country. Uruguay comprises a small territory (176.215 m2) and has only about 3.3 million inhabitants [11]. To this respect, the Gastroenterology Clinic from Hospital de Clínicas, though located in Montevideo (the capital city), is the only university reference centre where patients from all over the country and belonging to different socioeconomic backgrounds are referred to. Hence, since the patients were recruited from this centre, we conceive our samples to be fairly representative of Uruguayan HCV-infected population. Nevertheless, we share the idea proposed by the authors [1] that having nationwide surveys would provide larger samples to support our studies. However, it is worth mentioning that such an approach would be very difficult to carry out in our country given that our HCV infection prevalence among general population is currently unknown [12]. In conclusion, following this line of thought, we believe that generalizations about the frequency of HCV resistance-associated substitutions (RASs) in the whole country are reasonably accurate. The purpose of our study was to contribute with an initial assessment of the presence of RASs to NS5A/NS5B inhibitors in a direct-acting antiviral agent treatment naïve cohort of Uruguayan patients chronically infected with HCV, and therefore, we encourage further studies on HCV resistance patterns.

Finally, we thank the authors for their comments and the editor for giving us the opportunity to clarify the concerns.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Authors’ Contributions

Fabián Aldunate and Natalia Echeverría contributed equally to this work.

References

  1. S. Eybpoosh and M. Kiminezhad Malaie, “Comment on ‘Pretreatment hepatitis C virus NS5A/NS5B resistance-associated substitutions in genotype 1 Uruguayan infected patients’,” Disease Markers, vol. 2018, Article ID 8698263, 2 pages, 2018. View at: Publisher Site | Google Scholar
  2. F. Aldunate, N. Echeverría, D. Chiodi et al., “Pretreatment hepatitis C virus NS5A/NS5B resistance-associated substitutions in genotype 1 Uruguayan infected patients,” Disease Markers, vol. 2018, Article ID 2514901, 9 pages, 2018. View at: Publisher Site | Google Scholar
  3. M. Salemi, “Genetic distances and nucleotide substitution models – Practice,” in The Phylogenetic Handbook: A Practical Approach to Phylogenetic Analysis and Hypothesis Testing, P. Lemey, M. Salemi, and A. M. Vandamme, Eds., pp. 126–141, Cambridge University Press, Cambridge, UK, 2009. View at: Google Scholar
  4. G. Magiorkinis, E. Magiorkinis, D. Paraskevis et al., “The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis,” PLoS Medicine, vol. 6, no. 12, article e1000198, 2009. View at: Publisher Site | Google Scholar
  5. O. G. Pybus, M. A. Charleston, S. Gupta, A. Rambaut, E. C. Holmes, and P. H. Harvey, “The epidemic behavior of the hepatitis C virus,” Science, vol. 292, no. 5525, pp. 2323–2325, 2001. View at: Publisher Site | Google Scholar
  6. J. P. Allain, Y. Dong, A. M. Vandamme, V. Moulton, and M. Salemi, “Evolutionary rate and genetic drift of hepatitis C virus are not correlated with the host immune response: studies of infected donor-recipient clusters,” Journal of Virology, vol. 74, no. 6, pp. 2541–2549, 2000. View at: Publisher Site | Google Scholar
  7. K. Strimmer and A. von Haeseler, “Likelihood-mapping: a simple method to visualize phylogenetic content of a sequence alignment,” Proceedings of the National Academy of Sciences, vol. 94, no. 13, pp. 6815–6819, 1997. View at: Publisher Site | Google Scholar
  8. X. Xia and Z. Xie, “DAMBE: software package for data analysis in molecular biology and evolution,” Journal of Heredity, vol. 92, no. 4, pp. 371–373, 2001. View at: Publisher Site | Google Scholar
  9. X. Xia and P. Lemey, “Assessing substitution saturation with DAMBE - practice,” in The Phylogenetic Handbook: A Practical Approach to Phylogenetic Analysis and Hypothesis Testing, P. Lemey, M. Salemi, and A. M. Vandamme, Eds., pp. 624–630, Cambridge University Press, Cambridge, UK, 2009. View at: Google Scholar
  10. X. Xia, Z. Xie, M. Salemi, L. Chen, and Y. Wang, “An index of substitution saturation and its application,” Molecular Phylogenetics and Evolution, vol. 26, no. 1, pp. 1–7, 2003. View at: Publisher Site | Google Scholar
  11. Instituto Nacional de Estadística, Resultados del Censo de Población 2011, Instituto Nacional de Estadística, Montevideo, Uruguay, 2012.
  12. N. Echeverría, P. Moreno, and J. Cristina, “Molecular evolution of hepatitis C virus: from epidemiology to antiviral therapy (current research in Latin America),” in Human Virology in Latin America: From Biology to Control, J. E. Ludert, F. H. Pujol, and J. Arbiza, Eds., pp. 333–359, Springer International Publishing, 2017. View at: Google Scholar

Copyright © 2019 Fabián Aldunate et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

619 Views | 174 Downloads | 0 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.